Cocrystal Pharma, Inc.
COCP
$1.02
$0.010.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 225.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 225.00K | -- | -- | -- | -- |
| Cost of Revenue | 5.07M | 5.06M | 5.47M | 7.76M | 10.95M |
| Gross Profit | -4.84M | -5.06M | -5.47M | -7.76M | -10.95M |
| SG&A Expenses | 4.19M | 3.96M | 4.30M | 4.96M | 5.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.26M | 9.02M | 9.77M | 12.72M | 16.06M |
| Operating Income | -9.03M | -9.02M | -9.77M | -12.72M | -16.06M |
| Income Before Tax | -8.83M | -8.83M | -9.67M | -12.56M | -15.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.83 | -8.83 | -9.67 | -12.56 | -15.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.83M | -8.83M | -9.67M | -12.56M | -15.85M |
| EBIT | -9.03M | -9.02M | -9.77M | -12.72M | -16.06M |
| EBITDA | -8.98M | -8.95M | -9.68M | -12.62M | -15.95M |
| EPS Basic | -0.73 | -0.79 | -0.94 | -1.23 | -1.56 |
| Normalized Basic EPS | -0.46 | -0.49 | -0.58 | -0.77 | -0.97 |
| EPS Diluted | -0.73 | -0.79 | -0.94 | -1.23 | -1.56 |
| Normalized Diluted EPS | -0.46 | -0.49 | -0.58 | -0.77 | -0.97 |
| Average Basic Shares Outstanding | 48.76M | 45.15M | 41.51M | 40.70M | 40.70M |
| Average Diluted Shares Outstanding | 48.76M | 45.15M | 41.51M | 40.70M | 40.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |